Leonard L Mazur is Director of Hillstream BioPharma Inc.. Currently has a direct ownership of 123,733 shares of HILS, which is worth approximately $356,351. The most recent transaction as insider was on Jan 14, 2022, when has been sold 98,733 shares (Common Stock) at a price of $3.2 per share, resulting in proceeds of $315,946. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 124K
0% 3M change
0% 12M change
Total Value Held $356,351

Leonard L Mazur Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 14 2022
BUY
Conversion of derivative security
$315,946 $3.2 p/Share
98,733 Added 50.0%
98,733 Common Stock
Jan 14 2022
BUY
Open market or private purchase
$100,000 $4.0 p/Share
25,000 Added 16.81%
123,733 Common Stock

Also insider at

CTXR
Citius Pharmaceuticals, Inc. Healthcare
TENK
TenX Keane Acquisition
LLM

Leonard L Mazur

Director
Cranford, NJ

Track Institutional and Insider Activities on HILS

Follow Hillstream BioPharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HILS shares.

Notify only if

Insider Trading

Get notified when an Hillstream Bio Pharma Inc. insider buys or sells HILS shares.

Notify only if

News

Receive news related to Hillstream BioPharma Inc.

Track Activities on HILS